Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,965 | 13,752 | 11,651 | 12,589 | 66,574 |
| Marketable Securities | 62,903 | 80,400 | 99,607 | 107,921 | 59,029 |
| Other current assets | 1,046 | 2,081 | 1,611 | 1,311 | 421 |
| TOTAL | $93,953 | $99,213 | $114,201 | $122,616 | $127,318 |
| Non-Current Assets | |||||
| PPE Net | 238 | 225 | 245 | 170 | 68 |
| Other Non-Current Assets | 1,705 | 1,539 | 1,759 | 229 | 975 |
| TOTAL | $1,943 | $1,764 | $2,004 | $399 | $1,043 |
| Total Assets | $95,896 | $100,977 | $116,205 | $123,015 | $128,361 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 7,482 | 7,000 | 7,000 |
| Accounts payable and accrued liabilities | 1,256 | 1,352 | 1,983 | 2,857 | 2,333 |
| Accrued Expenses | 3,625 | 3,082 | 3,474 | 3,518 | 5,249 |
| TOTAL | $5,173 | $4,711 | $13,201 | $13,400 | $14,641 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | N/A | 0 | 2,151 | 3,800 |
| Other Non-Current Liabilities | 1,051 | 1,100 | 1,148 | 5 | 17 |
| TOTAL | $1,113 | $1,193 | $1,272 | $2,156 | $3,817 |
| Total Liabilities | $6,286 | $5,904 | $14,473 | $15,556 | $18,458 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,858 | 63,851 | 60,070 | 60,045 | 59,923 |
| Common Shares | 64 | 63 | 60 | 60 | 58 |
| Retained earnings | -231,313 | -223,615 | -216,470 | -210,069 | -204,564 |
| Other shareholders' equity | -217 | -248 | -88 | -122 | -263 |
| TOTAL | $89,610 | $95,073 | $101,732 | $107,459 | $109,903 |
| Total Liabilities And Equity | $95,896 | $100,977 | $116,205 | $123,015 | $128,361 |